Privacy Statement   Terms & Conditions   Sitemap  
  Diseases   Research   About us  
TBE Meningococcal Disease Influenza Smallpox
 


  Severity of TBE in relation to other CNS viral diseases

According to a study conducted in 1958, the proportion of TBE in the total number of CNS viral diseases in Austria was 56%. Thus, before the start of the vaccination program, it was the most important and most frequent disease of this type in adults with several hundred cases being reported each year.
In Switzerland, in 1981 TBE ranked fourth among viral infections of the central and peripheral nervous system, only picorna, mumps and Varicella zoster infections were more frequent. In some cantons, however, it was the most frequent cause of CNS diseases. In Germany, TBE accounts for up to 50% of all viral diseases, and in Lithuania TBE accounts for more than half (53%) of all CNS infections.


 » Printversion

 
 
  » find


 

Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
» read more

Baxter receives preparedness contract from Austrian Ministry of Health for Pandemic Influenza Vaccine
» read more

Baxter Announces Safety and Immunogenicity Results from Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine
» read more

 
Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,